Free Trial

Vicarious Surgical Q4 2023 Earnings Report

Vicarious Surgical logo
$14.09 -1.76 (-11.12%)
As of 01/21/2025 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Vicarious Surgical EPS Results

Actual EPS
-$2.10
Consensus EPS
-$3.60
Beat/Miss
Beat by +$1.50
One Year Ago EPS
-$4.80

Vicarious Surgical Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Vicarious Surgical Announcement Details

Quarter
Q4 2023
Time
After Market Closes

Conference Call Resources

Conference Call Audio

Vicarious Surgical Earnings Headlines

Vicarious Surgical Secures Advisory Role with Former CFO
Elon Musk: my AI will be “worth more than Tesla”
Tesla made Elon Musk the richest man in human history. And now, Elon's got a new AI project...
BTIG Sticks to Its Hold Rating for Vicarious Surgical (RBOT)
See More Vicarious Surgical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Vicarious Surgical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Vicarious Surgical and other key companies, straight to your email.

About Vicarious Surgical

Vicarious Surgical (NYSE:RBOT). operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

View Vicarious Surgical Profile

More Earnings Resources from MarketBeat